![]() |
市場調查報告書
商品編碼
1471306
螢光內視鏡市場:按產品、焦點、應用和最終用戶 - 2024-2030 年全球預測Fluorescence Endoscopy Market by Products (Accessories, Endoscope, Imaging System), Focusing (Electric, Manual), Application, End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年螢光內視鏡市場規模為81.1億美元,預計2024年將達87.2億美元,2030年將達到138.2億美元,複合年成長率為7.90%。
螢光內視鏡是一種微創成像技術,用於評估器官健康、診斷疾病和檢測癌細胞。由於幾個重要因素,螢光內視鏡已成為各種醫療應用中的重要診斷和手術工具。對標靶疾病檢測和治療的需求不斷成長,推動了對螢光內視鏡的需求。這項創新技術使醫療保健專業人員能夠更精確地可視化特定組織和異常情況,從而實現準確診斷和有針對性的干涉。此外,螢光內視鏡在生物科學中發揮重要作用,特別是在次世代定序儀應用中。研究人員擴大利用內視鏡螢光方法來促進基因序列的可視化和分析,從而推動基因組學和個人化醫療的進步。然而,與螢光內視鏡檢查相關的程序通常昂貴且耗時,這主要是由於需要專門的設備和專業知識。這些成本和時間因素是採用的障礙,特別是在資源有限的醫療保健環境中。然而,儘管存在這些挑戰,對微創診斷和外科手術的渴望、持續的技術改進以及不斷增加的研究和開發都在推動螢光內視鏡市場的擴張。隨著醫療保健產業不斷認知到螢光內視鏡檢查的好處,人們正在努力解決成本和時間問題、改善安全措施並提高這些程序的整體效率。螢光內視鏡有可能徹底改變診斷和治療性介入,並將在未來的醫學影像和精準醫學中發揮關鍵作用。
主要市場統計 | |
---|---|
基準年[2023] | 81.1億美元 |
預測年份 [2024] | 87.2億美元 |
預測年份 [2030] | 138.2億美元 |
複合年成長率(%) | 7.90% |
增加配件的使用,提高產品的耐用度和精度
光源、濾光片和顯影劑配件對於增強螢光內視鏡的功能至關重要。診所和醫院根據手術的複雜性和內視鏡設備的能力優先考慮其使用。高階配件耐用且精確,但對於小型診所或門診中心來說可能不划算。偏好通常與手術類型和患者周轉率一致。內視鏡檢查是利用螢光內視鏡進行醫療的中心。內視鏡的選擇通常基於影像解析度、景深和特定應用領域(例如胃腸病學或呼吸系統醫療設備)。內視鏡有多種類型,包括軟性內視鏡和硬性內視鏡,每種內視鏡都有各自的優點。軟式內視鏡是首選,因為它們可以輕鬆地穿過體內的彎曲途徑,而硬式內視鏡在可觸及區域提供更好的影像品質。成像系統的選擇是基於其與現有內視鏡設備整合的能力、可檢測的螢光類型以及增強影像分析和儲存的軟體功能。
焦點:更多採用電動螢光內視鏡系統,提供自動化和易用性
電動螢光內視鏡系統採用先進技術來增強醫療手術過程中組織和細胞的可視化。它們通常具有縮放、聚焦和濾鏡選擇等自動化功能,只需按一下按鈕即可進行調整。這些系統專為那些要求診斷和治療性介入準確、高效和彈性的醫生而設計。手動螢光內視鏡系統涉及更實際的方法,依賴操作內視鏡的醫務人員的技能和天賦。這些系統需要手動調整螢光過程中使用的濾光片和光源。
應用:檢查肺部和氣道的肺內視鏡檢查變得越來越重要。
在關節鏡中,使用內視鏡檢查和治療關節內部。關節鏡中的螢光內視鏡有助於執行微創手術來診斷和治療關節疾病,包括關節炎。支氣管鏡檢查是指一種內視鏡技術,可觀察氣道內部以進行診斷和治療。耳鼻喉鏡用於檢查和治療耳、鼻、喉疾病。使用螢光,內視鏡醫生可以更好地識別這些區域內的病理情況。胃腸道螢光內視鏡檢查增強了黏膜異常和癌性病變的檢測。在婦產科中,螢光內視鏡主要用於腹腔鏡手術。可用於子宮內膜異位症等的診斷和治療。肺內視鏡檢查與支氣管鏡檢查一樣,檢查肺部和氣道。螢光內視鏡檢查通常用於發現和切片檢查疑似癌變的病變。泌尿系統鏡檢查包括膀胱鏡檢查,可觀察膀胱和尿道。使用螢光,臨床醫生可以檢測、診斷和量化膀胱癌等疾病。
最終使用者:由於執行的手術範圍廣泛,醫院和診所將擴大引入螢光內視鏡檢查。
門診手術中心 (ASC) 是提供當天手術治療(包括診斷和預防程序)的醫療保健機構。 ASC 對螢光內視鏡的需求是由微創手術的需求驅動的,微創手術可以實現快速的患者周轉、降低感染率和具有成本效益的服務。由於執行的綜合程序和對先進診斷能力的需求,醫院和診所是螢光內視鏡檢查的最大部分。
區域洞察
螢光內視鏡是一種快速發展的醫學影像處理技術,已在世界各地廣受認可。北美醫療基礎設施發達,注重技術進步,在螢光內視鏡市場佔有很大佔有率。美國在將螢光內視鏡引入和整合到各個醫療領域方面處於領先地位。由於領先市場參與企業的存在、強大的研發力度以及慢性病盛行率的上升,區域螢光內視鏡市場正在擴大。在微創手術需求不斷成長和醫學影像技術進步的推動下,歐洲也是螢光內視鏡的主要市場之一。德國、英國和法國等國家擴大在醫院和診所採用螢光內視鏡,重點在於提高診斷準確性和改善病患治療效果。亞太地區螢光內視鏡市場也出現了顯著成長。在中國、日本和印度等國家,不斷上漲的醫療成本、不斷提高的先進診斷技術意識以及不斷增加的患者數量正在推動市場擴張。新興經濟體的存在以及對醫療基礎設施發展的日益重視為該地區的市場成長提供了充足的機會。
FPNV定位矩陣
FPNV定位矩陣對於評估螢光內視鏡市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對螢光內視鏡市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.螢光內視鏡市場規模及預測如何?
2.螢光內視鏡市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些?
3.螢光內視鏡市場的技術趨勢和法規結構是什麼?
4.螢光內視鏡市場主要廠商的市場佔有率是多少?
5.進入螢光內視鏡市場的合適型態和策略手段是什麼?
[189 Pages Report] The Fluorescence Endoscopy Market size was estimated at USD 8.11 billion in 2023 and expected to reach USD 8.72 billion in 2024, at a CAGR 7.90% to reach USD 13.82 billion by 2030.
Fluorescence endoscopy is a minimally invasive imaging technique used to assess organ health, diagnose disease, and detect tumor cells. Fluorescence endoscopy has emerged as a vital diagnostic and surgical tool in various medical applications, driven by several key factors. The increasing need for targeted disease detection and treatment has fueled the demand for fluorescence endoscopy. This innovative technique allows healthcare professionals to visualize specific tissues and abnormalities with enhanced precision, enabling accurate diagnosis and targeted interventions. Moreover, fluorescence endoscopy has found significant utility in biosciences, particularly next-generation sequencing applications. Researchers are increasingly leveraging fluorescence endoscopy methods to facilitate the visualization and analysis of genetic sequences, leading to advancements in genomics and personalized medicine. However, the procedures associated with fluorescence endoscopy are often expensive and time-consuming, primarily due to the specialized equipment and expertise required. This cost and time factor pose barriers to adoption, especially in resource-constrained healthcare settings. Nevertheless, despite these challenges, the desire for minimally invasive diagnostic and surgical procedures, continued technical improvements, and increased research and development efforts are all driving the market for fluorescence endoscopy to expand. As the healthcare industry continues to recognize the benefits of fluorescence endoscopy, efforts are being made to address the cost and time concerns, improve safety measures, and enhance the overall efficiency of these procedures. With the potential to revolutionize diagnostics and therapeutic interventions, fluorescence endoscopy is poised to play a significant role in the future of medical imaging and precision medicine.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 8.11 billion |
Estimated Year [2024] | USD 8.72 billion |
Forecast Year [2030] | USD 13.82 billion |
CAGR (%) | 7.90% |
Product: Growing usage of accessories that provide better durability and precision
Accessories, such as light sources, filters, and contrast agents, are pivotal for augmenting the functionality of fluorescence endoscopes. Clinics and hospitals prioritize these depending on the complexity of procedures and the endoscopy unit's capabilities. High-end accessories provide better durability and precision but may not be cost-effective for smaller clinics or outpatient centers. The preference typically aligns with the type of procedures and patient turnover. Endoscopes are central to the practice of fluorescence endoscopy. The selection is typically based on image resolution, depth of field, and the specific area of application, for example, gastroenterology or pulmonology. Endoscopes come in various types, such as flexible and rigid, each with its advantages. Flexible endoscopes may be favored for their ease of navigation through curvilinear paths in the body, while rigid provide better image quality in accessible areas. Imaging systems are selected based on their integration capabilities with existing endoscopic equipment, the types of fluorescence they can detect, and the software features that enhance image analysis and storage.
Focusing: Rising adoption of electric fluorescence endoscopy systems as they offer automation and ease of use
Electric fluorescence endoscopy systems use advanced technology to enhance the visualization of tissues and cells during medical procedures. They typically offer automated features such as zoom, focus, and filter selection that can be adjusted with the push of a button. These systems are designed for doctors who seek precision, efficiency, and flexibility in diagnostics and therapeutic interventions. Manual fluorescence endoscopy systems involve a more hands-on approach, relying on the skill and finesse of the medical professional to manipulate the endoscope. These systems require manual adjustment of the optical filters and light sources used in the fluorescence process.
Application: Increasing significance of pulmonary endoscopy for examining the lungs and air pathways
Arthroscopy involves endoscopic examination and treatment of the interior of a joint. Fluorescence endoscopy in arthroscopy helps in performing minimally invasive procedures to diagnose and treat joint diseases, including arthritis. Bronchoscopy refers to the endoscopic technique of visualizing the inside of the airways for diagnostic and therapeutic purposes. ENT endoscopy is used for examining and treating ear, nose, and throat conditions. Using fluorescence, endoscopists can better identify pathologies within these areas. Fluorescence endoscopy in the gastrointestinal tract enhances the detection of mucosal abnormalities or cancerous lesions. In obstetrics and gynecology, fluorescence endoscopy is predominantly used in laparoscopic procedures. It assists in diagnosing and treating conditions such as endometriosis. Pulmonary endoscopy, similar to bronchoscopy, involves examining the lungs and air pathways. Fluorescence endoscopy is often used to detect and biopsy lesions suspected of cancer. Urology endoscopy includes cystoscopy, which allows for visualization of the bladder and urethra. Using fluorescence, clinicians can detect, diagnose, and quantify diseases such as bladder cancer.
End-User: Expanding deployment of fluorescence endoscopy across hospitals & clinics due to the comprehensive range of procedures performed
Ambulatory surgery centers (ASCs) are healthcare facilities that provide same-day surgical care, including diagnostic and preventive procedures. The need for fluorescence endoscopy in ASCs is driven by the demand for minimally invasive surgeries that allow for quicker patient turnover, reduced infection rates, and cost-effective services. Hospitals & clinics represent the largest segment for fluorescence endoscopy due to the comprehensive range of procedures performed and the need for advanced diagnostic capabilities.
Regional Insights
Fluorescence endoscopy is a rapidly growing medical imaging technology that has gained significant traction worldwide. North America, with its well-established healthcare infrastructure and high emphasis on technological advancements, holds a significant share of the fluorescence endoscopy market. The United States has been at the forefront of adopting and integrating fluorescence endoscopy into various medical specialties. The fluorescence endoscopy market in this region is expanding with the existence of major market participants, strong research and development efforts, and the rising prevalence of chronic diseases. Europe is another prominent market for fluorescence endoscopy, driven by the rising demand for minimally invasive procedures and advancements in medical imaging technologies. Countries such as Germany, the United Kingdom, and France have witnessed widespread adoption of fluorescence endoscopy in hospitals and clinics, focusing on improving diagnostic accuracy and patient outcomes. The Asia-Pacific region is also experiencing significant growth in the fluorescence endoscopy market. Rising healthcare expenditure, increasing awareness about advanced diagnostic techniques, and a large patient population contribute to the expanding market in countries such as China, Japan, and India. The presence of emerging economies and a growing emphasis on healthcare infrastructure development presents ample opportunities for market growth in this region.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Fluorescence Endoscopy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Fluorescence Endoscopy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Fluorescence Endoscopy Market, highlighting leading vendors and their innovative profiles. These include Adronic Instrument Manufacturing Co., Ltd., AMNOTEC International Medical GmbH, Arthrex, Inc., B. Braun Melsungen AG, Boston Scientific Corporation, Carl Zeiss AG, ConMed Corporation, ERBE Elektromedizin GmbH, Haitai Xinguang, Healnoc, Hoya Corporation, Karl Storz SE & Co. KG, Medtronic PLC, Modulight Corp., Nanjing Nuoyuan Medical Devices Co., Ltd., Olympus Corporation, OptoMedic, PENTAX Medical, Richard Wolf GmbH, SCHOLLY FIBEROPTIC GMBH, Scivita Medical Technology Co., Ltd., Smith & Nephew PLC, STERIS Corporation, Stryker Corporation, Suzhou Caring Medical Co., Ltd., and Tuge Medical.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Fluorescence Endoscopy Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Fluorescence Endoscopy Market?
3. What are the technology trends and regulatory frameworks in the Fluorescence Endoscopy Market?
4. What is the market share of the leading vendors in the Fluorescence Endoscopy Market?
5. Which modes and strategic moves are suitable for entering the Fluorescence Endoscopy Market?